|
|
|
Volumn 34, Issue , 2016, Pages 96-99
|
|
The Corrona US registry of rheumatic and autoimmune diseases
|
|
Author keywords
Biological agents; Corrona; Cost effectiveness; Registry; Rheumatoid arthritis
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
HYDROXYCHLOROQUINE;
METHOTREXATE;
PLACEBO;
RHEUMATOID FACTOR;
SALAZOSULFAPYRIDINE;
ANTIRHEUMATIC AGENT;
BIOLOGICAL PRODUCT;
ARTICLE;
AUTOIMMUNE DISEASE;
CLINICAL PRACTICE;
DAS28;
DISEASE ACTIVITY;
DISEASE REGISTRY;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTITIONER;
GOVERNMENT;
HUMAN;
INFLAMMATORY BOWEL DISEASE;
INTERVENTION STUDY;
OUTCOME ASSESSMENT;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RHEUMATOID ARTHRITIS;
RHEUMATOLOGIST;
SPONDYLOARTHROPATHY;
AUTOIMMUNE DISEASES;
COST BENEFIT ANALYSIS;
DRUG COST;
ECONOMICS;
REGISTER;
RHEUMATIC DISEASES;
RHEUMATOLOGY;
TIME FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ANTIRHEUMATIC AGENTS;
AUTOIMMUNE DISEASES;
BIOLOGICAL PRODUCTS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HUMANS;
REGISTRIES;
RHEUMATIC DISEASES;
RHEUMATOLOGY;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 85018299436
PISSN: 0392856X
EISSN: 1593098X
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (48)
|
|
References (3)
|
